Sampriti Pal

SP

Statistics

Publications

2

Citations

259

H-Index

2

Active since

2020

Sampriti Pal is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in diabetes mellitus, glucagon-like peptide-1 receptor agonists, and diabetes treatment adherence.

Publications per year

2020–2022

2

Publications

2